adenosine has been researched along with Non-ST Elevated Myocardial Infarction in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (87.50) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Adriaans, BP; Bekkers, SCAM; Bijvoet, GP; Crijns, HJGM; Gerretsen, SC; Heijman, J; Kim, RJ; Mingels, AMA; Schalla, S; Smulders, MW; Theunissen, RALJ; van Cauteren, YJM; van Kuijk, SMJ; Wildberger, JE | 1 |
| Cho, JY; Cho, SA; Hong, SJ; Jeong, HS; Joo, HJ; Kim, JH; Lee, SH; Lim, DS; Park, JH; Yu, CW | 1 |
| Adamska, U; Adamski, P; Buszko, K; Gorog, DA; Kubica, A; Kubica, J; Laskowska, E; Marszałł, MP; Navarese, EP; Ostrowska, M; Paciorek, P; Rość, D; Sikora, A; Sikora, J; Skibińska, N; Sobczak, P; Umińska, JM | 1 |
| Carugo, S; Castini, D; Cazzaniga, S; Centola, M; Ferrante, G; Lucreziotti, S; Persampieri, S; Salerno-Uriarte, D; Sponzilli, C | 1 |
| Dong, C; Liu, X; Ren, C; Ren, Q; Zhang, X | 1 |
| Cheema, AN; Cieza, T; Dehghani, P; Déry, JP; Fisher, HN; Goodman, SG; Henderson, MA; Kokis, A; Lavi, S; Lutchmedial, S; Mehta, SR; Siega, AJ; Welsh, RC; Wong, BY; Zhang, X; Zhu, YE | 1 |
| Holm, M; Rihan Hye, S; Tornvall, P; van der Linden, J; Westerberg, J | 1 |
| Andolina, G; Carella, M; Castellana, C; Coppola, G; Corrado, E; Evola, S; Novo, G; Novo, S; Raso, S; Sucato, V | 1 |
3 trial(s) available for adenosine and Non-ST Elevated Myocardial Infarction
| Article | Year |
|---|---|
Cardiovascular magnetic resonance accurately detects obstructive coronary artery disease in suspected non-ST elevation myocardial infarction: a sub-analysis of the CARMENTA Trial.
Topics: Acute Coronary Syndrome; Adenosine; Aged; Coronary Artery Disease; Coronary Stenosis; Female; Humans; Magnetic Resonance Imaging, Cine; Male; Middle Aged; Myocardial Perfusion Imaging; Non-ST Elevated Myocardial Infarction; Predictive Value of Tests; Reproducibility of Results; Vasodilator Agents | 2021 |
Comparison of Ticagrelor Versus Prasugrel for Inflammation, Vascular Function, and Circulating Endothelial Progenitor Cells in Diabetic Patients With Non-ST-Segment Elevation Acute Coronary Syndrome Requiring Coronary Stenting: A Prospective, Randomized,
Topics: Acute Coronary Syndrome; Adenosine; Adult; Aged; Anti-Inflammatory Agents; Biomarkers; Brachial Artery; Cross-Over Studies; Diabetes Mellitus, Type 2; Endothelial Progenitor Cells; Female; Humans; Inflammation Mediators; Male; Middle Aged; Non-ST Elevated Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Prospective Studies; Purinergic P2Y Receptor Antagonists; Seoul; Stents; Ticagrelor; Time Factors; Treatment Outcome; Vasodilation | 2017 |
Ticagrelor pharmacokinetics and pharmacodynamics in patients with NSTEMI after a 180-mg loading dose.
Topics: Adenosine; Adenosine Diphosphate; Aged; Biotransformation; Blood Platelets; Coronary Artery Disease; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Non-ST Elevated Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation; Platelet Aggregation Inhibitors; Prospective Studies; Purinergic P2Y Receptor Antagonists; Sweden; Ticagrelor | 2017 |
5 other study(ies) available for adenosine and Non-ST Elevated Myocardial Infarction
| Article | Year |
|---|---|
Comparison of bioavailability and antiplatelet action of ticagrelor in patients with ST-elevation myocardial infarction and non-ST-elevation myocardial infarction: A prospective, observational, single-centre study.
Topics: Adenosine; Aged; Biological Availability; Blood Platelets; Female; Humans; Male; Middle Aged; Non-ST Elevated Myocardial Infarction; Platelet Aggregation Inhibitors; Prospective Studies; Purinergic P2Y Receptor Antagonists; ST Elevation Myocardial Infarction; Ticagrelor | 2017 |
Real-world clopidogrel utilization in acute coronary syndromes: patients selection and outcomes in a single-center experience.
Topics: Acute Coronary Syndrome; Adenosine; Aged; Aged, 80 and over; Chi-Square Distribution; Clopidogrel; Drug Prescriptions; Drug Therapy, Combination; Drug Utilization Review; Female; Hemorrhage; Hospital Mortality; Humans; Italy; Logistic Models; Male; Middle Aged; Multivariate Analysis; Non-ST Elevated Myocardial Infarction; Patient Selection; Platelet Aggregation Inhibitors; Practice Patterns, Physicians'; Prasugrel Hydrochloride; Purinergic P2Y Receptor Antagonists; Risk Factors; Ticagrelor; Ticlopidine; Time Factors; Treatment Outcome | 2017 |
Ticagrelor vs. clopidogrel in non-ST-elevation acute coronary syndromes.
Topics: Acute Coronary Syndrome; Adenosine; Bradycardia; Clopidogrel; Comorbidity; Electrocardiography; Female; Germany; Humans; Male; Non-ST Elevated Myocardial Infarction; Prevalence; Purinergic P2Y Receptor Antagonists; Risk Factors; Survival Rate; Ticagrelor; Ticlopidine; Treatment Outcome | 2016 |
Baseline characteristics, adenosine diphosphate receptor inhibitor treatment patterns, and in-hospital outcomes of myocardial infarction patients undergoing percutaneous coronary intervention in the prospective Canadian Observational AntiPlatelet sTudy (C
Topics: Adenosine; Adult; Aged; Aged, 80 and over; Canada; Clopidogrel; Drug Substitution; Emergency Medical Services; Emergency Service, Hospital; Female; Hemorrhage; Hospitalization; Humans; Longitudinal Studies; Male; Middle Aged; Myocardial Infarction; Non-ST Elevated Myocardial Infarction; Percutaneous Coronary Intervention; Prasugrel Hydrochloride; Prospective Studies; Purinergic P2Y Receptor Antagonists; ST Elevation Myocardial Infarction; Ticagrelor; Ticlopidine; Young Adult | 2016 |
Real-world use of ticagrelor and prasugrel in patients with NSTEMI undergoing percutaneous coronary intervention.
Topics: Adenosine; Aged; Female; Humans; Male; Middle Aged; Non-ST Elevated Myocardial Infarction; Percutaneous Coronary Intervention; Prasugrel Hydrochloride; Purinergic P2Y Receptor Antagonists; Retrospective Studies; Ticagrelor; Treatment Outcome | 2017 |